跳至主要内容
临床试验/NCT01792427
NCT01792427已完成不适用

Mortality in Non-cystic Fibrosis Bronchiectasis: a Long-term Cohort Analysis

Universitaire Ziekenhuizen KU Leuven1 个研究点 分布在 1 个国家目标入组 253 人开始时间: 2006年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
253
试验地点
1
主要终点
overall survival

研究概览

简要总结

In this study we analyzed the overall survival for all newly diagnosed patients with non-cystic fibrosis bronchiectasis from June 2006 onwards. The investigators wanted to confirm the known risk factors such as age, gender, smoking history and Pseudomonas aeruginosa and evaluate the impact on survival of etiology, number of different bacteriological species in retrospective and prospective sputa, azithromycin use and presence/development of pulmonary hypertension.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with clinically significant and radiologically proven bronchiectasis
  • Chest CT scan confirming the presence of bronchiectatic lesions and had symptoms of chronic productive cough
  • Bronchiectasis was deemed to be present if there was one or more of the following criteria: a bronchoarterial ratio greater than 1, lack of tapering of the bronchi and visualization of bronchi within 1 cm of costal or paravertebral pleura or abutting the mediastinal pleura

排除标准

  • diagnosis of cystic fibrosis
  • underlying tumoral problem causing the bronchiectatic lesions (postradiotherapy, secondary immunodeficiency due to chemotherapy or postinfectious due to tumoral obstruction)
  • patients with asymptomatic traction bronchiectasis caused by interstitial lung disease

结局指标

主要结局

overall survival

时间窗: 6 years 4 months

次要结局

  • risk factor identification for NCFB(6 years 4 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Lieven Dupont

prof. dr.

Universitaire Ziekenhuizen KU Leuven

研究点 (1)

Loading locations...

相似试验